RA Prescribing Patterns Shift Over 15 Years - Scorecard - MDSpire

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

  • By

  • Kathryn Wighton

  • May 29, 2026

  • 5 min

Share

Clinical Scorecard: RA Prescribing Patterns Shift Over 15 Years

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingSingle-center study in a rural area in Japan, emphasizing the unique demographic.

Key Highlights

  • mean_SDAI_change

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • d
      • d
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • r
      • e
      • c
      • o
      • m
      • m
      • e
      • n
      • d
      • a
      • t
      • i
      • o
      • n
      • s
      • f
      • o
      • r
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • r
      • e
      • n
      • a
      • l
      • f
      • u
      • n
      • c
      • t
      • i
      • o
      • n
      • a
      • n
      • d
      • p
      • o
      • t
      • e
      • n
      • t
      • i
      • a
      • l
      • d
      • r
      • u
      • g
      • i
      • n
      • t
      • e
      • r
      • a
      • c
      • t
      • i
      • o
      • n
      • s
      • .

      Risks

        Patient & Prescribing Data

        Include implications of declining methotrexate doses on patient outcomes.

        Clinical Best Practices

        • add_renal_monitoring

        Related Resources & Content

        Original Source(s)

        RA Prescribing Patterns Shift Over 15 Years

        • by Kathryn Wighton

        • May 29, 2026

        Related Content

        Identification of ferroptosis hub gene cDKN1A relating to immune microenvironment in rheumatoid arthritis via bioinformatic analysis and experimental verification

        CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis

        A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice

        • June 30, 2026

        • 3 min
        Predicting anti-CCP positivity and early rheumatoid arthritis onset from routine laboratory parameters: a SHAP-explained machine learning pipeline